Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.66 USD | -0.25% | -0.41% | -15.80% |
Apr. 30 | Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer | CI |
Mar. 08 | Akero Therapeutics Raises $367 Million From Share Offering | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.36B |
---|---|---|---|---|---|
Net income 2024 * | -233M | Net income 2025 * | -274M | EV / Sales 2024 * | - |
Net cash position 2024 * | 388M | Net cash position 2025 * | 282M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.99
x | P/E ratio 2025 * |
-4.38
x | Employees | 56 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.32% |
Latest transcript on Akero Therapeutics, Inc.
1 day | -0.25% | ||
1 week | -0.41% | ||
Current month | -1.16% | ||
1 month | -14.41% | ||
3 months | -5.53% | ||
6 months | +34.84% | ||
Current year | -15.80% |
Managers | Title | Age | Since |
---|---|---|---|
Jonathan Young
FOU | Founder | 54 | 17-03-31 |
Timothy Rolph
FOU | Founder | 70 | 17-03-31 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 18-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Seth Harrison
BRD | Director/Board Member | 63 | 16-12-31 |
Jane Henderson
BRD | Director/Board Member | 58 | 19-04-22 |
Mark Iwicki
CHM | Chairman | 57 | 18-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.18% | 0 M€ | 0.00% | - | |
0.12% | 237 M€ | +1.82% | - | |
0.10% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 19.66 | -0.25% | 543,557 |
24-05-02 | 19.71 | -1.84% | 439,719 |
24-05-01 | 20.08 | +0.96% | 1,054,519 |
24-04-30 | 19.89 | +1.38% | 749,604 |
24-04-29 | 19.62 | -0.61% | 452,634 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.80% | 1.36B | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- AKRO Stock